Revolution Medicines (RVMD) Enterprise Value (2020 - 2026)
Revolution Medicines' Enterprise Value was $36.19 billion in Q2 2026, up 663.6% from $4.74 billion a year earlier and up 106.1% from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Enterprise Value (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Revolution Medicines' Enterprise Value was $30.32 billion through Jun 30, 2026; for FY2025, it came in at $13.67 billion, up 133.9% from FY2024.
- Enterprise Value shows a five-year compound annual growth rate of 51.2% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $5.84 billion in FY2024 (+319.6%), $1.39 billion in FY2023 (-7.7%), $1.51 billion in FY2022 (+17.0%) and $1.29 billion in FY2021 (-25.6%).
- The Q2 2026 figure marks the highest quarterly Enterprise Value in data going back to Q1 2020.
- Compared with a year earlier, Enterprise Value has increased for four straight quarters, with growth averaging 202.3% over the last eight quarters.
- The best year-over-year quarter for Enterprise Value over five years was Q2 2026 (growth of 663.6%); the worst was Q1 2022 (a decline of 48.8%).
- Per Business Quant data, RVMD's Enterprise Value in the three quarters before Q2 2026 was $17.56 billion (Q1 2026), $13.67 billion (Q4 2025) and $6.93 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.19 Bn |
| Mar 31, 2026 | 17.56 Bn |
| Dec 31, 2025 | 13.67 Bn |
| Sep 30, 2025 | 6.93 Bn |
| Jun 30, 2025 | 4.74 Bn |
| Mar 31, 2025 | 4.48 Bn |
| Dec 31, 2024 | 5.84 Bn |
| Sep 30, 2024 | 6.06 Bn |
| Jun 30, 2024 | 4.84 Bn |
| Mar 31, 2024 | 3.61 Bn |
| Dec 31, 2023 | 1.39 Bn |
| Sep 30, 2023 | 2.22 Bn |
| Jun 30, 2023 | 2.01 Bn |
| Mar 31, 2023 | 1.39 Bn |
| Dec 31, 2022 | 1.51 Bn |
| Sep 30, 2022 | 1.08 Bn |
| Jun 30, 2022 | 989.83 Mn |
| Mar 31, 2022 | 1.37 Bn |
| Dec 31, 2021 | 1.29 Bn |
| Sep 30, 2021 | 1.42 Bn |
API Access
Revolution Medicines Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();